Vedanta Biosciences, Inc
The human body is an ecosystem. Trillions of microbes call us home. They form the human microbiome, which performs critical functions that preserve our health including modulating our immune system and providing colonization resistance against infectious pathogens. Alterations of the human microbiome are increasingly recognized as a key factor in development of immune and infectious diseases. We rationally design medicines based on consortia of human commensal bacteria to treat disease, using insights from microbial ecology, mucosal immunology, and human interventional studies. Our platform enables identification of defined bacterial consortia with drug-like properties and their manufacture to GMP standards.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
About Us
Dutch scientist Antonie van Leeuwenhoek is the first person to observe bacteria, by scraping plaque from his own teeth and inspecting it through one of his handcrafted microscopes. His pioneering work contributed to establishing microbiology as a scientific discipline.
Photo Credit: Photo by Don Hamerman
Carl Woese rewrites the Tree of Life with the discovery of Archaea. He pioneers the use of marker genes such as the 16S ribosomal gene as a method to distinguish between microbial lineages, greatly expanding our knowledge of the microbial world.
Efforts by Vedanta cofounder Dan Littman lead to the identification and cloning of CD4 and CD8, molecules on the surface of T cells that are crucial to immune recognition and response.